Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ESI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSolstice to acquire Element Solutions in $6.8B revenue combination, targets $180M+ synergies
Filed July 20, 2026 · Period ending July 20, 2026 · ~2 min read
Key Changes
-
high
Solstice Advanced Materials announced definitive agreement to acquire Element Solutions Inc, creating combined company with $6.8B in 2025 revenue and $1.7B adjusted EBITDA (including year 3 synergies), with enhanced exposure to electronics markets including advanced packaging and semiconductor materials.
Exhibit 99.1 view on EDGAR → -
high
Transaction expected to generate $180M+ in run-rate synergies by year 3 (potential $210M), accretive to adjusted EPS in year 1, with combined adjusted EBITDA margins expected to reach 26% (28% excluding metals pass-through) and medium-term free cash flow conversion of ~75%.
Exhibit 99.1 view on EDGAR → -
high
Pro forma net leverage of 3.5x at close (3.1x with synergies); management committed to deleveraging below 3.0x within 18 months and maintaining 2.0x-3.0x long-term target, with ~50% of cash flow over next 24 months allocated to debt repayment.
Exhibit 99.1 view on EDGAR → -
high
Solstice's nuclear business remains core growth pillar with $2B+ backlog, 10+ kt/yr conversion capacity contracted through 2030, and expected double-digit EBITDA CAGR through 2030 as expanding portion of combined business mix.
Exhibit 99.1 view on EDGAR → -
medium
Transaction requires stockholder approval from both companies and regulatory clearances; Solstice to file Form S-4 registration statement with joint proxy statement/prospectus. Solstice secured $4.7B in committed bridge financing.
Item 7.01 — Regulation FD Disclosure verify on EDGAR →
Summary
Solstice Advanced Materials disclosed an investor presentation detailing its proposed acquisition of Element Solutions Inc, a transaction that would create a $6.8 billion revenue advanced materials company with significant exposure to high-growth electronics markets.
The combination targets over $180 million in annual synergies by year 3, driven by footprint optimization, supply chain improvements, and operational savings, and is expected to be accretive to adjusted EPS in the first year while expanding combined EBITDA margins to 26-28%. The deal carries meaningful leverage implications for ESI shareholders.
Pro forma net leverage sits at 3.5x at close (3.1x including synergies), above typical investment-grade comfort zones, though management has committed to deleveraging below 3.0x within 18 months by allocating roughly half of near-term cash flow to debt repayment. Solstice has secured $4.7 billion in committed bridge financing to fund the transaction. The combined company plans to maintain long-term leverage between 2.0x and 3.0x while continuing organic growth investments and capital returns. For ESI holders, the strategic rationale centers on enhanced scale in electronics end-markets and the preservation of Solstice's nuclear growth trajectory, which management expects to deliver double-digit EBITDA growth through 2030 on a $2 billion-plus backlog. The transaction requires stockholder approval from both companies and regulatory clearances; Solstice will file a Form S-4 registration statement containing the joint proxy materials.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Solstice issued an investor update presentation regarding its proposed acquisition of Element Solutions Inc.
Added in current filing · verify on EDGAR →
On July 20, 2026, Solstice Advanced Materials Inc., a Delaware corporation (“Solstice”) issued an investor update presentation regarding the proposed acquisition of Element Solutions Inc, a Delaware corporation (“Element Solutions”) by Solstice.
Solstice Advanced Materials Inc. issued an investor update presentation on July 20, 2026 regarding its proposed acquisition of Element Solutions Inc. The presentation is attached as Exhibit 99.1 to this 8-K filing. This disclosure provides updated information to investors about the pending transaction between the two specialty chemicals companies.
Added in current filing · verify on EDGAR →
In connection with the proposed transaction, Solstice intends to file with the SEC a registration statement on Form S-4 (the “Registration Statement”), which will include a prospectus with respect to the shares of Solstice’s common stock to be issued in the proposed transaction and a joint proxy statement for Solstice’s and Element Solutions’ respective stockholders (the “Joint Proxy Statement/Prospectus”).
Solstice intends to file a registration statement on Form S-4 with the SEC that will include both a prospectus for the shares to be issued in the acquisition and a joint proxy statement for stockholders of both companies. The definitive joint proxy statement/prospectus will be mailed to stockholders after it is declared effective by the SEC. This represents a procedural step forward in the merger process requiring stockholder approval from both companies.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
anticipated synergies of $180+ million by Year 3; accretive to growth, adj. EPS, adj. EBITDA margins, and cash conversion
The transaction is expected to generate over $180 million in run-rate synergies by year 3, with a run-rate potential of approximately $210 million. Synergies are expected to come from footprint optimization (~$20M), supply chain improvements (~$25M), operational savings (~$100M), and other opportunities (~$35M). The deal is anticipated to be accretive to adjusted EPS in year 1 and to enhance combined adjusted EBITDA margins to 26% (28% excluding metals pass-through). Medium-term combined free cash flow conversion is expected to reach approximately 75%.
Added in current filing · view on EDGAR →
Anticipated enhanced cash profile and conservative 3.1x synergized net leverage* (3.5x excluding synergies) – enables both deleveraging and ongoing investment in key growth initiatives
At closing, the combined company expects net leverage of approximately 3.5x excluding synergies, or 3.1x including year 3 synergies of $180 million. Management is committed to deleveraging below 3.0x within 18 months post-close and maintaining a long-term target net leverage range of 2.0x to 3.0x. The company has secured $4.7 billion in committed bridge financing and expects to allocate approximately 50% of cash flow over the next 24 months to debt repayment while continuing organic growth investments and capital returns to shareholders.
Added in current filing · view on EDGAR →
Nuclear expected to remain a core growth pillar for Solstice – $2+ bn of backlog and an expected double - digit EBITDA CAGR through 2030; Nuclear is an expanding portion of the overall business mix
Solstice's nuclear business is positioned as a core growth pillar with over $2 billion in high-quality order backlog and production capacity largely contracted through 2030. The company has 10+ kt/yr annual conversion capacity and a valid NRC license through 2060. Management expects double-digit annual nuclear EBITDA growth through 2030, with the nuclear segment representing an expanding portion of the overall business mix post-transaction.
Added in current filing · verify on EDGAR →
In connection with the proposed transaction, Solstice intends to file with the SEC a registration statement on Form S ... - 4 (the “Registration Statement”), which will include a prospectus with respect to the shares of Solstice’s common stock to be issued in the propos ... ed transaction and a joint proxy statement for Solstice’s and Element Solutions’ respective stockholders
The transaction requires approval from stockholders of both Solstice and Element Solutions, as well as regulatory approvals. Solstice will file a registration statement on Form S-4 with the SEC containing a joint proxy statement/prospectus. The filing indicates the transaction structure involves Solstice issuing shares of its common stock to Element Solutions stockholders. No specific closing timeline is disclosed in this 8-K.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 23, 2026 · How we verify